IPO Rush: Groww, Three SME Issues To Open For Bidding This Week

IPO Rush: Groww, Three SME Issues To Open For Bidding This Week

IPO Rush: Groww, Three SME Issues To Open For Bidding This Week

This week, the Indian stock market is set to witness a flurry of initial public offerings (IPOs), with Groww’s parent company, Billionbrains Garage Ventures Ltd., being the highlight. The company, backed by Microsoft Chief Executive Officer Satya Nadella, is set to offer a fresh issue of shares worth Rs 1,060 crore, as well as an offer for sale of Rs 55.72 crore.

Apart from the Groww IPO, there are no mainboard IPOs scheduled for this week. However, market participants will see listings of two mainboard companies: Orkla India Ltd. and Studds Accessories Ltd. The LensKart Solutions IPO, which opened for subscription on Friday, will conclude its subscription on November 4.

Groww IPO Details

Fresh issue: Rs 1,060 crore

Offer for sale: Rs 55.72 crore

Price band: Rs 95–100 apiece

Lot size: 150

Issue Type: Book-building IPO

Tentative Allotment: November 10

Tentative Listing: November 12

Listing At: BSE, National Stock Exchange

SME Issues

In the small-medium enterprise segment, Sreeji Global FMCG Ltd., Finbud Financial Services Ltd., and Curis Lifesciences Ltd.’s IPOs will open for subscription.

Sreeji Global FMCG Ltd.’s IPO is opening for subscription on November 4 and will close on November 7. The total issue is worth Rs 85 crore. The price band for the issue is Rs 120 to Rs 125 apiece. The tentative allotment date is November 10, and the tentative listing is on November 12.

SME IPOs offer a chance to invest in small, high-potential companies, but they also come with higher risks and lower liquidity compared to mainboard issues. Here are the three SME IPOs opening for subscription this week.

1. Sreeji Global FMCG Ltd.

Operating in the fast-moving consumer goods (FMCG) sector, Sreeji Global is likely involved in the distribution and marketing of a range of consumer products. The FMCG sector is known for its resilience, but competition is intense. Investors should look at the company’s distribution network, brand portfolio, and regional dominance.

  • Issue Period: Nov 4 to Nov 7
  • Total Issue Size: ₹85 Crore
  • Price Band: ₹120 – ₹125 per share
  • Tentative Listing Date: Nov 12

2. Finbud Financial Services Ltd.

Finbud Financial Services likely operates as a Non-Banking Financial Company (NBFC), providing loans and financing solutions. The key for investors here is to assess the company’s loan book quality, net interest margins (NIMs), and asset quality (NPAs). The financial services sector is sensitive to interest rate cycles and economic health.

  • Issue Period: Nov 6 to Nov 10
  • Total Issue Size: ₹71.68 Crore
  • Price Band: ₹140 – ₹142 per share
  • Tentative Listing Date: Nov 13

3. Curis Lifesciences Ltd.

As the name suggests, Curis Lifesciences operates in the pharmaceutical or life sciences space. This could range from manufacturing generic drugs to providing specific healthcare products. The pharma sector has strong long-term potential, but is subject to stringent regulatory approvals (like USFDA) and R&D risks. Investors should analyse its product pipeline and market approvals.

  • Issue Period: Nov 7 to Nov 11
  • Total Issue Size: ₹27.52 Crore
  • Price Band: ₹120 – ₹128 per share
  • Tentative Listing Date: Nov 14

Action in the Secondary Market: Key Listings in Focus

The primary market’s success is ultimately tested on listing day. This week, two companies that recently concluded their IPOs will make their debut on the stock exchanges. The performance of these listings will be a crucial indicator of the secondary market’s health and investor appetite.

1. Orkla India Ltd. Listing

Orkla India, a major player in the packaged foods industry known for its MTR and Eastern brands, saw a strong response to its IPO. After a stellar subscription of over 40 times, all eyes will be on its listing performance. A strong debut would reaffirm investor confidence in established consumer brands with solid fundamentals. Investors who were allotted shares will need to decide whether to book profits on listing day or hold for the long term, based on the company’s growth prospects and the listing premium.

2. Studds Accessories Ltd. Listing

Studds Accessories is a leading manufacturer of helmets and two-wheeler accessories. Given the massive two-wheeler market in India and the increasing focus on road safety, the company is well-positioned for growth. Its IPO was also well-received, particularly by retail investors. The listing performance will be a test of investor belief in the ‘Make in India’ and auto ancillary theme. A positive listing could provide a boost to the broader manufacturing sector.


Last Call: LensKart Solutions IPO Subscription Closes Nov 4

A quick reminder for investors: the IPO of another major consumer tech brand, LensKart Solutions, which opened for subscription last Friday, will close this week on November 4. The omni-channel eyewear retailer has a strong presence both online and offline. The issue has already seen healthy subscription figures, indicating strong investor interest. Those looking to bid for the IPO should do so before the window closes.


Conclusion: An Action-Packed Week for the Discerning Investor

This week is a testament to the vibrancy and depth of the Indian capital markets. From a fintech unicorn’s mega IPO to niche SME offerings and crucial mainboard listings, there is something for every type of investor.

The star of the show is undoubtedly the Groww IPO. It offers a chance to participate in India’s digital transformation story. However, investors must look past the brand name, assess the high valuation, and be mindful of the competitive and regulatory risks.

The SME issues, while smaller in size, are crucial for the market ecosystem and offer high-growth potential for those with a higher risk appetite. Finally, the listings of Orkla and Studds will set the tone for the secondary market’s receptiveness to new entrants.

As always, we advise all investors to conduct their own thorough due diligence. Read the Red Herring Prospectus (RHP) carefully, understand the business and its risks, and consult a qualified financial advisor before making any investment decisions. A busy week lies ahead on Dalal Street – navigate it wisely.

Disclaimer: The information provided in this article is for educational purposes only and should not be construed as investment advice. The Grey Market Premium (GMP) is an unofficial metric and is not a guarantee of listing gains. Please consult with your financial advisor before investing.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top